UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033017
Receipt number R000037638
Scientific Title Time-dependent coagulation changes in acute normovolemic hemodilutional blood
Date of disclosure of the study information 2018/07/01
Last modified on 2021/06/29 11:20:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Time-dependent coagulation changes in acute normovolemic hemodilutional blood

Acronym

Coagulation status of acute normovolemic hemodilutional blood

Scientific Title

Time-dependent coagulation changes in acute normovolemic hemodilutional blood

Scientific Title:Acronym

Coagulation status of acute normovolemic hemodilutional blood

Region

Japan


Condition

Condition

Malignancy

Classification by specialty

Hepato-biliary-pancreatic medicine Surgery in general Obstetrics and Gynecology
Oto-rhino-laryngology Orthopedics Cardiovascular surgery
Blood transfusion

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine how long the acute normovolemic hemodilutional blood maintains the coagulation status.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

A10 and maximum clot firmness (MCF) of INTEM, EXTEM and FIBTEM (ROTEM deltaTM) of autologous blood

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who receive acute normovolemic hemodilution under general anesthesia

Key exclusion criteria

Patients who refuse to join the study

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Junichi
Middle name
Last name Saito

Organization

Hirosaki University Graduate School of Medicine

Division name

Department of Anesthesiology

Zip code

0358563

Address

zaifu-cho 5, Hirosaki, Aomori, Japan

TEL

0172-39-5113

Email

saitoj@hirosaki-u.ac.jp


Public contact

Name of contact person

1st name Junichi
Middle name
Last name Saito

Organization

Hirosaki University Graduate School of Medicine

Division name

Department of Anesthesiology

Zip code

0368563

Address

zaifu-cho 5, Hirosaki, Aomori, Japan

TEL

0172-39-5113

Homepage URL


Email

saitoj@hirosaki-u.ac.jp


Sponsor or person

Institute

Hirosaki University Graduate School of Medicine, department of Anesthesiology

Institute

Department

Personal name



Funding Source

Organization

Hirosaki University Graduate School of Medicine, department of Anesthesiology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

institutional review board, Hirosaki University Graduate School of Medicine

Address

zaifu-cho5, Hirosaki

Tel

0172335113

Email

saitoj@hirosaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2018 Year 06 Month 10 Day

Date of IRB

2018 Year 06 Month 11 Day

Anticipated trial start date

2018 Year 07 Month 01 Day

Last follow-up date

2020 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

we evaluate the coagulation status of the autologous blood. we measure twice using with ROTEM deltaTM just after withdrawing the blood and just before retransfusion to the patients.


Management information

Registered date

2018 Year 06 Month 15 Day

Last modified on

2021 Year 06 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037638


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name